Indications
Therapeutic Asset Ratings
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Oxaliplatin
Urinary Bladder Carcinoma
Arcus Biosciences, Inc.
P2
BB
(71)
Oxaliplatin
Endometrial Carcinoma
Qilu Pharmaceutical Co., Ltd.
P2
BB
(71)
Oxaliplatin
Mantle Cell Lymphoma
National Cancer Institute (NCI)
P2
BB
(71)
Palbociclib
Her2-Receptor Negative Breast Cancer
Helwan University
P2
BB
(71)
Prednisone
MALT Lymphoma
SWOG Cancer Research Network
P2
BB
(71)
Prednisone
Melanoma
National Cancer Institute (NCI)
P2
BB
(71)
Prednisone
Metastatic Melanoma
National Cancer Institute (NCI)
P2
BB
(71)
Prednisone
Nodal Marginal Zone B-Cell Lymphoma
SWOG Cancer Research Network
P2
BB
(71)
Sargramostim
Ovarian Cancer
Aston Sci. Inc.
P2
BB
(71)
Tisotumab Vedotin
Non-Small Cell Lung Carcinoma
Seagen, a wholly owned subsidiary of Pfizer
P2
BB
(71)
Trastuzumab
Lung Cancer
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
P2
BB
(71)
Vinorelbine Ditartrate
Small Cell Lung Carcinoma
Central European Society for Anticancer Drug Research
P2
BB
(71)
Alemtuzumab
Bone Marrow Failure Syndrome
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2/3
BB
(71)
Alemtuzumab
Fanconi Anemia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2/3
BB
(71)
Busulfanum
Bone Marrow Failure Syndrome
Memorial Sloan Kettering Cancer Center
P2/3
BB
(71)
Cladribine
Myelodysplastic Syndrome
University of Florida
P2/3
BB
(71)
Fludarabine
Severe Combined Immunodeficiency
National Institute of Allergy and Infectious Diseases (NIAID)
P2/3
BB
(71)
Fludeoxyglucose
Prostate Carcinoma
Jonsson Comprehensive Cancer Center
P2/3
BB
(71)
Memantine
Major Depressive Disorder
Jeffrey Miller
P2/3
BB
(71)
Nivestim
Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome
City of Hope Medical Center
P2/3
BB
(71)
Nivolumab
Gliosarcoma
Andrew P. Groves
P2/3
BB
(71)
Rituximab
Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma Of The Elderly
University of Washington
P2/3
BB
(71)
Rituximab
T-Cell/Histiocyte Rich Large B Cell Lymphoma
Ruijin Hospital
P2/3
BB
(71)
Sirolimus
Childhood Acute Myeloid Leukemia
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
P2/3
BB
(71)
Venetoclax
Chronic Myelomonocytic Leukemia
Servier Bio-Innovation LLC
P2/3
BB
(71)
Showing 2476 to 2500 of 42,285 assets
Previous
Page 100 of 1692
Next